Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

CE Marking & contract renewal

13th Dec 2006 07:01

International Medical Devices PLC13 December 2006 13 December 2006 International Medical Devices PLC ("IMD" or the "Company") CE Marking granted and contract renewal Highlights • ClipOn safe needle receives CE Marking for sales and distribution inEurope • Renewed contract with the Ministry of Defence for supply of WelchAllyn Defibrillators International Medical Devices Plc (AIM: INT), the fast-growing medical supplycompany targeting the medical consumables, cardiorespiratory, acute and agedcare markets, announces the completion of the CE Marking process on the 'ClipOn'safe needle, full launch of the product expected Q1 2007, and a further contractwith Welch Allyn for the supply of the PIC 50 Portable Intensive CareDefibrillator Units to the Ministry of Defence ("MoD"). ClipOn needles On 12 December 2006, IMD received full CE Marking for the ClipOn safe needle.IMD owns the patents for ClipOn in the UK, Eire, Spain, Portugal, France, Italy,Greece, Austria, Belgium, the Netherlands, Luxembourg, Denmark, Sweden, Norway,Finland, the United States of America, Canada and Mexico. ClipOn is designed toeliminate needlestick injuries amongst healthcare professionals due to itsrevolutionary design that allows the ClipOn needle to attach to all standardsyringes. The CE Marking now provides the Company with the legal certificate tosell and distribute ClipOn to healthcare markets throughout these countries.Product marketing and sales will commence in Q1 2007. IMD is also initiating anapplication for U.S. Food and Drug Administration (FDA) approval for ClipOn inorder to target the North American markets in the second half of 2007. Defibrillators Response Medical, IMD's wholly owned subsidiary has been supplying the WelchAllyn PIC 50 Defibrillators to the Ministry of Defence since 2001 and the MoDhas renewed its contract, reaffirming the continued supply of the product. Dueto its rugged yet lightweight design, it is ideal to be used by the MoD inoperational zones as it is capable of withstanding the varying environmentalconditions imposed by use in the defence forces. Commenting on the latest product update, CEO Chris Thomas stated: "The updated MoD contract with Welch Allyn demonstrates the reliability of ourdefibrillator range and we are very happy to continue our relationship with theMinistry of Defence. To receive the CE marking on our ClipOn safe needle is asignificant step forward. ClipOn can become one of the principal products indriving the Company's organic growth to help reach our goal of becoming one ofthe major medical distributors in the UK and Europe. We have already receivedorders from the NHS for ClipOn. With an estimated global market for unsafeneedles of 6 billion needles per year, IMD's challenge is to substitute Clip Onin the key markets in Western Europe and the Americas, for which IMD owns thepatents." ENDS International Medical Devices Corporate Synergy Parkgreen CommunicationsChris Thomas Ian Rice Victoria ThomasCEO+44 203 008 4960 +44 117 933 0020 +44 207 493 3713 Notes to Editors About IMD: International Medical Devices Plc was admitted to AIM in November 2004 with thepurpose of acquiring companies or businesses operating in the health and medicaldevices sector which have the prospect of delivering high return and significantcapital growth. Since September 2005, IMD has made three acquisitions that, in its audited 2006financial statements, gave the IMD group a pro forma turnover of in excess of£10million. www.imd-plc.com This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Intelliam Ai
FTSE 100 Latest
Value10,416.62
Change-36.06